Risk factor analysis for the major hazards following heart transplantation—rejection, infection, and coronary occlusive disease

LD SHARPLES, N CAINE, P MULLINS… - …, 1991 - journals.lww.com
This study demonstrates the importance of analyzing survival by cause of death in order to
achieve a better understanding of the prognostic indicators involved. It further emphasizes the …

An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris …

…, JY Ryan, C Freeman, N Caine… - European heart …, 2006 - academic.oup.com
Aims Refractory angina pectoris leads to significant morbidity. Treatment options include
percutaneous myocardial laser revascularization (PMR) and spinal cord stimulation (SCS). This …

Cost-effectiveness of ventricular assist device use in the United Kingdom: results from the evaluation of ventricular assist device programme in the UK (EVAD-UK)

…, NR Banner, SR Large, S Tsui, N Caine… - The Journal of heart and …, 2006 - Elsevier
BACKGROUND: The UK Department of Health funds ventricular assist device (VAD)
implantation as a bridge to transplantation (BTT) at three centers. The cost-effectiveness of this …

Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital.

C Dennis, N Caine, L Sharples, R Smyth… - The Journal of heart …, 1993 - europepmc.org
Between October 1985 and July 1992 we performed heart-lung transplantation in 42 patients
with end-stage respiratory disease caused by cystic fibrosis. Twenty-eight of these patients …

Measurement of health-related quality of life before and after heart-lung transplantation.

N Caine, LD Sharples, C Dennis… - The Journal of heart …, 1996 - europepmc.org
Background The measurement of the quality of the outcome of treatment as viewed by
patients is becoming increasingly recognized as an important aspect of decision making in all …

Heart and lung transplantation for terminal cystic fibrosis: A 4˝-year experience

…, JP Scott, MJ Elliott, L Sharples, N Caine… - The Journal of Thoracic …, 1991 - Elsevier
From among 112 patients with cystic fibrosis who were assessed for heart-lung transplantation,
83 were accepted. Twenty-six died while awaiting heart-lung transplantation and 32 had …

Percutaneous myocardial laser revascularization in patients with refractory angina pectoris

…, SC Clarke, S Tait, LD Sharples, N Caine… - The American journal of …, 2003 - Elsevier
This study aimed to determine the safety and efficacy of percutaneous myocardial laser
revascularization (PMLR). Seventy-three patients with stable angina pectoris (class III or IV) who …

Use of a rare disease patient registry in long-term post-authorisation drug studies: a model for collaboration with industry

D Bilton, N Caine, S Cunningham… - The lancet Respiratory …, 2018 - thelancet.com
The financial agreement between the UKCFT and the marketing authorisation holder ensures
that the company covers all the costs of conducting the study and that none of the work is …

[HTML][HTML] Long-term safety study of colistimethate sodium (Colobreathe®): Findings from the UK Cystic Fibrosis Registry

S Kaplan, A Lee, N Caine, SC Charman… - Journal of Cystic …, 2021 - Elsevier
Background As part of the risk management plan in Europe, a long-term observational study
was conducted to monitor the safety of colistimethate sodium dry powder for inhalation (CMS…

Evaluation of the clinical effectiveness of the Ventricular Assist Device Program in the United Kingdom (EVAD UK)

…, A Khaghani, SR Large, S Tsui, N Caine… - The Journal of heart and …, 2007 - Elsevier
BACKGROUND: The UK Government funds ventricular assist device (VAD) implantation as
bridge to transplantation (BTT) at three centers. Results from this program have not been …